WCCT Global announces continued success in Japanese bridging clinical trials

WCCT Global has been recognized as an industry leader when it comes to ethno bridging studies, specifically focused on Japanese population groups. Their process for recruiting and retaining the Japanese volunteers has set the industry standard for US based Japanese bridging clinical research.

The most recent study required WCCT Global to screen 115 first generation Japanese volunteers which was done successfully. The goal for this study was to enroll 68 first generation Japanese into the study but WCCT Global was able to surpass that amount and enroll 83 volunteers.

This over-enrollment is attributed to WCCT Global’s targeted recruitment methods and outreach to the Japanese community in Southern California to spark interest about clinical trial participation.

WCCT Global has a Japanese call line so when potential volunteers call their facility, they are able to speak to their in-house fluent Japanese recruitment specialist who creates a seamless process to give all study information and conduct prescreening in the Japanese language.

WCCT Global Early Clinical Development executive director of Edward Kim noted the company is excited to be able to share such amazing news about its recruitment and screening efforts.

"Our ability to exceed enrollment by more than 20% for this study is a testament to WCCT Global’s commitment to patient recruitment and retention efforts," Kim added.

With the increase of therapies being created by Japanese sponsors wanting to be in the US market, choosing an experienced full service CRO is crucial to the outcome of the study. WCCT Global will continue to assist Japanese sponsors reach their goals in the 2014 and beyond.